Bone Biologics Corp (BBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,334 | 3,325 | 3,027 | 7,538 | 6,675 |
| Receivables | 10 | N/A | N/A | N/A | N/A |
| Other current assets | 209 | 258 | 329 | 580 | 0 |
| TOTAL | $5,796 | $3,861 | $3,738 | $8,495 | $6,675 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $5,796 | $3,861 | $3,738 | $8,495 | $6,675 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 418 | 373 | 361 | 105 | 100 |
| Accrued Expenses | N/A | N/A | 415 | N/A | N/A |
| Other current liabilities | 1 | 5 | 56 | 2,443 | N/A |
| TOTAL | $419 | $378 | $831 | $2,548 | $100 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $419 | $378 | $831 | $2,548 | $100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,795 | 545 | 89 | 12 | N/A |
| Common Shares | 2 | 1 | 1 | 0 | 10 |
| Retained earnings | -88,130 | -85,021 | -80,909 | -71,960 | -70,476 |
| TOTAL | $5,378 | $3,484 | $2,906 | $5,947 | $6,576 |
| Total Liabilities And Equity | $5,796 | $3,861 | $3,738 | $8,495 | $6,675 |